A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation

Clinical trial NCT06005974 · TERMINATED

Trial details

NCT number: NCT06005974
Sponsor: Recursion Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

AXIN1 Gene Mutation APC Gene Mutation Solid Tumor

Start date: 2024-01-15
Primary completion: 2025-02-24
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.